Suboxone buprenorphine/naloxone sublingual film regulatory update

Reckitt's Reckitt Benckiser Pharmaceuticals Inc. subsidiary said FDA approved 4 mg/1 mg and 12 mg/3 mg dose formulations of Suboxone buprenorphine/naloxone sublingual film to treat opioid dependency. ...